Ascend Wellness Holdings (AAWH) Receivables - Other (2020 - 2025)
Ascend Wellness Holdings' (AAWH) quarterly Receivables - Other came in at $3.7 million in Q4 2025, down 4.57% year-on-year from $3.8 million in Q4 2024, and up 1917.58% quarter-over-quarter from $182000.0 in Q3 2025.
Ascend Wellness Holdings (AAWH) Receivables - Other (2020 - 2025) Analysis & Trends
Ascend Wellness Holdings' Receivables - Other history runs 6 years deep, the most recent figure standing at $3.7 million for Q4 2025.
- On a quarterly basis, Receivables - Other fell 4.57% year-over-year to $3.7 million in Q4 2025; TTM through Dec 2025 was $3.7 million, a 4.57% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 4.57% from the prior year.
- Receivables - Other advanced to $3.7 million in Q4 2025 per AAWH's latest filing, from $182000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $4.4 million in Q2 2021 and bottomed at $152000.0 in Q1 2021.
- The 5-year median for Receivables - Other is $170500.0 (2023), against an average of $960600.0.
- Across the five-year window, Receivables - Other sank 96.37% in 2022 and jumped 2163.53% in 2024, its largest moves.
- Year by year, Receivables - Other stood at $156000.0 in 2021, then advanced by 4.49% to $163000.0 in 2022, then grew by 4.29% to $170000.0 in 2023, then soared by 2163.53% to $3.8 million in 2024, then slipped by 4.57% to $3.7 million in 2025.
- Per Business Quant, the three latest AAWH Receivables - Other figures stand at $3.7 million (Q4 2025), $182000.0 (Q3 2025), and $180000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.67 Mn |
| Dec 31, 2025 | 3.67 Mn |
| Sep 30, 2025 | 182,000.00 |
| Sep 30, 2025 | 182,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 404,000.00 |
| Mar 31, 2025 | 404,000.00 |
| Dec 31, 2024 | 3.85 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 175,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 171,000.00 |
| Mar 31, 2024 | 171,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Sep 30, 2023 | 168,000.00 |
| Sep 30, 2023 | 168,000.00 |